Board of Directors
Our Board of Directors consists of seven to nine members with diverse professional backgrounds and extensive experience.
All directors perform their duties in accordance with applicable laws and the Company’s Articles of Incorporation, safeguarding the interests of both the Company and its shareholders. They prudently evaluate and decide on business strategies and policies to enhance corporate performance and protect shareholder rights.
Board Members
Jessica Wu
Chairman
- Chairman, TWi Biotechnology, Inc.
- Director, TWi Pharmaceuticals, Inc.
- Senior Advisor, Xinchen Investment Co., Ltd.
- Head of International Investment Banking, Executive Vice President, KGI Securities
- President, Prudence Capital Management Co., Ltd.
- President, Global Financial Services Co., Ltd.
- Vice President & Chief Representative in Beijing, Lehman Brothers Asia Ltd.
- Assistant Vice President, Chase Manhattan Bank, N.A., Taipei Branch
- Master of Arts in Economics, Indiana University, USA
- Bachelor of Business Administration, National Taiwan University, Taiwan
Dr. Chen-En Tsai
Director
- President & Chief Medical Officer, TWi Biotechnology, Inc.
- Vice President, Clinical Development, OBI Pharma, Inc.
- Clinical Reviewer & Senior Researcher, Taiwan Center for Drug Evaluation
- Vice President, Clinical Development, TaiGen Biotechnology Co., Ltd.
- Medical Advisor, Bristol-Myers Squibb (Taiwan and Hong Kong)
- Director, Department of Pediatrics, Hualien Tzu Chi Hospital, Taiwan
- Pediatrician, National Taiwan University Hospital, Taiwan
- Ph.D. in Molecular Genetics and Biology, University of Cambridge, UK
- M.D., College of Medicine, National Taiwan University, Taiwan
Ariel Chen
Director
- President, Xinchen Investment Co., Ltd.
- Credit & Interest Rates Trader, JPMorgan Chase Bank (Taiwan)
- Master of Business Administration in International Business (Finance), National Cheng Kung University, Taiwan
Dr. Andrew Yueh
Director
- Investigator, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan
- Postdoctoral Research Fellow, Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Columbia University, USA
- Ph.D. in Biochemistry, School of Medicine, New York University, USA
- M.S. Life Science, National Tsing-Hua University, Taiwan
Dr. Jonas Wang
Independent Director
- Chairman, StemCyte, Inc.
- Partner, Sycamore Ventures, USA
- Member, J&J Consumer Products Worldwide Licensing & Acquisition Committee
- Vice President of Research and Technology, Consumer Products, Johnson & Johnson, USA
- Associate Director, Basic Pharmaceuticals, Pharmaceutical Research Institute of Bristol Myers Squibb
- Ph.D in Physical Pharmacy, University of Iowa, USA
- Bachelor in Pharmacy, National Defense Medical Center, Taiwan
Roy Chang
Independent Director
- Secretary General, Taiwan Virtual Asset Service Provider Association
- Independent Director, DV Biomed Co., Ltd.
- Independent Director, Advanced Wireless & Antenna, Inc.
- Deputy Secretary General, Securities Analysts Association, Taiwan
- Vice President, Listing Examination Department, Taipei Exchange, Taiwan
- Lecturer, Securities & Futures Institute
- Master of Business Administration, Rutgers University, USA
Dr. Edward Chang
Independent Director
- Chairman, Taipei Bio-Industry Association, Taiwan
- Senior Advisor, Development Center for Biotechnology, Taiwan
- Chairman, Maxigen Biotech Inc.
- Independent Director, UBI Pharma Inc.
- President, China Investment and Development Co., Ltd.
- Vice President, Development Center for Biotechnology, Taiwan
- Associate Investigator, Cold Spring Harbor Laboratory, USA
- Distinguished Fellow, National Institutes of Health, USA
- Associate Professor, School of Medicine, New York University, USA
- Postdoctoral Fellow, School of Medicine, Harvard University, USA
- Ph.D. in Bacteriology, University of Wisconsin-Madison, USA